MENU
Session 3: October 26, 2021 9:00 AM CDT

A Microsatellite Instability (MSI) Series

MSI has rapidly advanced as an important pan tumor biomarker associated with response to immune checkpoint inhibitors and the drive towards universal tumor testing. 

Join Session 3 to learn more about MSI from two esteemed speakers who will present on the following topics:

  • Performance of the industry's first and only PCR-based diagnostic kit for MSI characterization (FDA-cleared)
  • The most current clinical practice guidelines for MSI testing
  • MSI detection using PCR followed by capillary electrophoresis (CE) analysis
  • The clinical utility of the MSI biomarker for Lynch syndrome screening and immunotherapy treatment
  • Compare techniques used to measure MSI to current gold-standard methods

In addition to the presentations, you will have the opportunity to: 

  • Peruse our booth to view instrument demonstrations from our sample-to-answer workflow for MSI analysis
  • Connect with Promega Clinical Consultants and Medical Affairs representatives
  • View the presentations from Session 1 and 2 where our speakers discussed the history, testing strategies and current trends for MSI testing and why MSI status should be a universal testing approach
Speakers
  • Presenter headshot of Dr. Emily Teslow
    Dr. Emily Teslow,  Ph.D.
    Medical Science Liaison, Medical Affairs Dept, Promega Corporation
  • Presenter headshot of Dr. Kathryn Oostdik
    Kathryn Oostdik
    Sr. Global Product Manager, Clinical Diagnostics, Promega Corporation

Speakers
  • Kathryn Oostdik

    Sr. Global Product Manager, Clinical Diagnostics, Promega Corporation
    BIOGRAPHY
  • Dr. Emily Teslow, Ph.D.

    Medical Science Liaison, Medical Affairs Dept, Promega Corporation
    BIOGRAPHY
  • Dr. Ryan Nguyen, DO

    Chief Hematology and Oncology Fellow, University of Illinois at Chicago
    BIOGRAPHY
  • Dr. Samantha Lewis, Ph.D.

    Clinical Development Specialist, Promega Corporation
    BIOGRAPHY
  • Dr. Pamela Ward, Ph.D.

    Associate Professor of Clinical Pathology, Scientific Director, USC Clinical Laboratories, Molecular Pathology
    BIOGRAPHY
  • Jeff Bacher, PhD

    Senior Research Scientist, Promega Corporation, Adjunct Professor, UW-Madison, Dept. of Medicine
    BIOGRAPHY
  • James Eshleman, MD, PhD

    Professor of Pathology and Oncology, Associate Director, Molecular Diagnostics Laboratory, Johns Hopkins University School of Medicine
    BIOGRAPHY
  • Heather Hampel, MS

    LGC Associate Director, Division of Human Genetics, Associate Director, Biospecimen Research Professor, Internal Medicine, Licensed Genetic Counselor, The Ohio State University Cancer Center
    BIOGRAPHY
  • Gerard Blobe, MD, PhD

    Professor of Medicine, Pharmacology and Cancer Biology at Duke University School of Medicine, Associate Director of Training and Education for the Duke Cancer Institute
    BIOGRAPHY

Show Resources
You May Also Like
DEC 07, 2021 12:30 PM EST
DEC 07, 2021 12:30 PM EST
Date: December 7, 2021 Time: 12:30-5:00 p.m. ET #NCATS10...
APR 19, 2022 6:00 AM PDT
APR 19, 2022 6:00 AM PDT
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
JAN 25, 2022 1:00 AM PST
JAN 25, 2022 1:00 AM PST
Europe - 10:00 AM Central European Time United Kingdom - 10:00 AM British Summer Time North America - 10:00 AM Central Standard Time Lab Compliance Connect – The world’s leading...
SEP 06, 2022 6:00 AM PDT
SEP 06, 2022 6:00 AM PDT
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
NOV 10, 2021 6:00 AM PST
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Twelve years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event...
NOV 09, 2022 6:00 AM PST
NOV 09, 2022 6:00 AM PST
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
Speakers
  • Current Gold-Standards for MSI Testing and the Clinical Relevance of the MSI-H Biomarker
    Oct 26, 2021 11:00 AM CDT
    Current Gold-Standards for MSI Testing and the Clinical Relevance of the MSI-H Biomarker
    Dr. Emily Teslow, Ph.D.
    Medical Science Liaison, Medical Affairs Dept, Promega Corporation
    BIOGRAPHY
  • Performance of the OncoMate™ MSI Dx Analysis System
    Oct 26, 2021 12:00 PM CDT
    Performance of the OncoMate™ MSI Dx Analysis System
    Kathryn Oostdik
    Sr. Global Product Manager, Clinical Diagnostics, Promega Corporation
    BIOGRAPHY
  • Tracking MSI status in liquid biopsies from MSI-H colorectal cancer subjects on immunotherapy
    JUN 29, 2021 11:15 AM CDT
    Tracking MSI status in liquid biopsies from MSI-H colorectal cancer subjects on immunotherapy
    Dr. Pamela Ward, Ph.D.
    Associate Professor of Clinical Pathology, Scientific Director, USC Clinical Laboratories, Molecular Pathology
    BIOGRAPHY
  • Development of a Microsatellite Instability Assay Utilizing Novel Long Repeats
    JUN 29, 2021 10:40 AM CDT
    Development of a Microsatellite Instability Assay Utilizing Novel Long Repeats
    Dr. Samantha Lewis, Ph.D.
    Clinical Development Specialist, Promega Corporation
    BIOGRAPHY
  • Colorectal Cancer Disparities and the Role of MSI Testing and Implementation
    JUN 29, 2021 10:00 AM CDT
    Colorectal Cancer Disparities and the Role of MSI Testing and Implementation
    Dr. Ryan Nguyen, DO
    Chief Hematology and Oncology Fellow, University of Illinois at Chicago
    BIOGRAPHY
  • Clinical Testing and Implication of MSI Testing in GI Cancers
    Clinical Testing and Implication of MSI Testing in GI Cancers
    Gerard Blobe, MD, PhD
    Professor of Medicine, Pharmacology and Cancer Biology at Duke University School of Medicine, Associate Director of Training and Education for the Duke Cancer Institute
    BIOGRAPHY
  • Universal Tumor Screening for Lynch Syndrome: Past, Present and Future
    Universal Tumor Screening for Lynch Syndrome: Past, Present and Future
    Heather Hampel, MS
    LGC Associate Director, Division of Human Genetics, Associate Director, Biospecimen Research Professor, Internal Medicine, Licensed Genetic Counselor, The Ohio State University Cancer Center
    BIOGRAPHY
  • MSI Predicts Immunotherapeutic Response
    MSI Predicts Immunotherapeutic Response
    James Eshleman, MD, PhD
    Professor of Pathology and Oncology, Associate Director, Molecular Diagnostics Laboratory, Johns Hopkins University School of Medicine
    BIOGRAPHY
  • Past, Present and Future: Advances in MSI Testing
    Past, Present and Future: Advances in MSI Testing
    Jeff Bacher, PhD
    Senior Research Scientist, Promega Corporation, Adjunct Professor, UW-Madison, Dept. of Medicine
    BIOGRAPHY
Agenda
On Demand Sessions

  • Colorectal Cancer Disparities and the Role of MSI Testing and Implementation
    Colorectal Cancer Disparities and the Role of MSI Testing and Implementation
    Dr. Ryan Nguyen, DO
    Chief Hematology and Oncology Fellow, University of Illinois at Chicago
    BIOGRAPHY
     
     
  • Development of a Microsatellite Instability Assay Utilizing Novel Long Repeats
    Development of a Microsatellite Instability Assay Utilizing Novel Long Repeats
    Dr. Samantha Lewis, Ph.D.
    Clinical Development Specialist, Promega Corporation
    BIOGRAPHY
     
     
  • Tracking MSI status in liquid biopsies from MSI-H colorectal cancer subjects on immunotherapy
    Tracking MSI status in liquid biopsies from MSI-H colorectal cancer subjects on immunotherapy
    Dr. Pamela Ward, Ph.D.
    Associate Professor of Clinical Pathology, Scientific Director, USC Clinical Laboratories, Molecular Pathology
    BIOGRAPHY
     
     
  • Clinical Testing and Implication of MSI Testing in GI Cancers
    Clinical Testing and Implication of MSI Testing in GI Cancers
    Gerard Blobe, MD, PhD
    Professor of Medicine, Pharmacology and Cancer Biology at Duke University School of Medicine, Associate Director of Training and Education for the Duke Cancer Institute
    BIOGRAPHY
     
     
  • Universal Tumor Screening for Lynch Syndrome: Past, Present and Future
    Universal Tumor Screening for Lynch Syndrome: Past, Present and Future
    Heather Hampel, MS
    LGC Associate Director, Division of Human Genetics, Associate Director, Biospecimen Research Professor, Internal Medicine, Licensed Genetic Counselor, The Ohio State University Cancer Center
    BIOGRAPHY
     
     
  • MSI Predicts Immunotherapeutic Response
    MSI Predicts Immunotherapeutic Response
    James Eshleman, MD, PhD
    Professor of Pathology and Oncology, Associate Director, Molecular Diagnostics Laboratory, Johns Hopkins University School of Medicine
    BIOGRAPHY
     
     
  • Past, Present and Future: Advances in MSI Testing
    Past, Present and Future: Advances in MSI Testing
    Jeff Bacher, PhD
    Senior Research Scientist, Promega Corporation, Adjunct Professor, UW-Madison, Dept. of Medicine
    BIOGRAPHY
     
     

C.E. Credits

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


Help

General Labroots Questions

email support@labroots.com  

Virtual Events and Webinars

Supported Configurations

  • Operating System Internet Explorer Firefox Chrome Safari
    Vista IE8+ FF10+ Chrome15+
    Windows 7 IE8+ FF10+ Chrome15+
    Windows 8 IE10 FF10+ Chrome15+
    Mac OS X   FF10+ Chrome15+ Safari5.1+
  • Cookie settings: session cookies enabled
  • Browser configuration must have JavaScript enabled
  • Adobe Flash player 10.2 or later

To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

Internet Connection

  • A minimum of 100Kbps is recommended for audio-only events
  • A minimum of 300Kbps is recommended for speaker on-video events

Computer Equipment

  • Screen Resolution: Minimum 1024x768
  • Video Card: 65,000 colors minimum
  • Sound card and speakers (or headphones) for hearing webcast in full format
  • Audio Card: 16-bit minimum
  • RAM: 512MB of free RAM

Firewall Protocol

  • HTTP on port 80 or HTTPS on port 443
  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

Work-At-Home Attendees

  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

For A Seamless Experience

When using a mobile device, FREE Mobile Apps are available:

- For viewing Webinars:

- For viewing Virtual Events

Attendee Guide

  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

Virtual Event and Webinar Support:

Continuing Education (CME/CE) Support

Loading Comments...
Show Resources